Global Cancer Gene Therapy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Cancer Gene Therapy market size was valued at US$ 510.7 million in 2023. With growing demand in downstream market, the Cancer Gene Therapy is forecast to a readjusted size of US$ 1674.2 million by 2030 with a CAGR of 18.5% during review period.
The research report highlights the growth potential of the global Cancer Gene Therapy market. Cancer Gene Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cancer Gene Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cancer Gene Therapy market.
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Cancer Gene Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cancer Gene Therapy market. It may include historical data, market segmentation by Type (e.g., Oncolytic Virotherapy, Gene Transfer), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cancer Gene Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cancer Gene Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cancer Gene Therapy industry. This include advancements in Cancer Gene Therapy technology, Cancer Gene Therapy new entrants, Cancer Gene Therapy new investment, and other innovations that are shaping the future of Cancer Gene Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cancer Gene Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Cancer Gene Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cancer Gene Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cancer Gene Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cancer Gene Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cancer Gene Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cancer Gene Therapy market.
Market Segmentation:
Cancer Gene Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Cancer Gene Therapy market size was valued at US$ 510.7 million in 2023. With growing demand in downstream market, the Cancer Gene Therapy is forecast to a readjusted size of US$ 1674.2 million by 2030 with a CAGR of 18.5% during review period.
The research report highlights the growth potential of the global Cancer Gene Therapy market. Cancer Gene Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cancer Gene Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cancer Gene Therapy market.
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Cancer Gene Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cancer Gene Therapy market. It may include historical data, market segmentation by Type (e.g., Oncolytic Virotherapy, Gene Transfer), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cancer Gene Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cancer Gene Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cancer Gene Therapy industry. This include advancements in Cancer Gene Therapy technology, Cancer Gene Therapy new entrants, Cancer Gene Therapy new investment, and other innovations that are shaping the future of Cancer Gene Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cancer Gene Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Cancer Gene Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cancer Gene Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cancer Gene Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cancer Gene Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cancer Gene Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cancer Gene Therapy market.
Market Segmentation:
Cancer Gene Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Oncolytic Virotherapy
- Gene Transfer
- Gene-Induced Immunotherapy
- Hospitals
- Diagnostics Centers
- Research Institutes
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Adaptimmune
- Bluebird bio
- Celgene
- Shanghai Sunway Biotech
- Shenzhen SiBiono GeneTech
- SynerGene Therapeutics
- Altor BioScience
- Amgen
- Argenx
- BioCancell
- GlaxoSmithKline
- Merck
- OncoGenex Pharmaceuticals
- Transgene
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cancer Gene Therapy Market Size 2019-2030
2.1.2 Cancer Gene Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cancer Gene Therapy Segment by Type
2.2.1 Oncolytic Virotherapy
2.2.2 Gene Transfer
2.2.3 Gene-Induced Immunotherapy
2.3 Cancer Gene Therapy Market Size by Type
2.3.1 Cancer Gene Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
2.4 Cancer Gene Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics Centers
2.4.3 Research Institutes
2.5 Cancer Gene Therapy Market Size by Application
2.5.1 Cancer Gene Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cancer Gene Therapy Market Size Market Share by Application (2019-2024)
3 CANCER GENE THERAPY MARKET SIZE BY PLAYER
3.1 Cancer Gene Therapy Market Size Market Share by Players
3.1.1 Global Cancer Gene Therapy Revenue by Players (2019-2024)
3.1.2 Global Cancer Gene Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CANCER GENE THERAPY BY REGIONS
4.1 Cancer Gene Therapy Market Size by Regions (2019-2024)
4.2 Americas Cancer Gene Therapy Market Size Growth (2019-2024)
4.3 APAC Cancer Gene Therapy Market Size Growth (2019-2024)
4.4 Europe Cancer Gene Therapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Cancer Gene Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Cancer Gene Therapy Market Size by Country (2019-2024)
5.2 Americas Cancer Gene Therapy Market Size by Type (2019-2024)
5.3 Americas Cancer Gene Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Gene Therapy Market Size by Region (2019-2024)
6.2 APAC Cancer Gene Therapy Market Size by Type (2019-2024)
6.3 APAC Cancer Gene Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cancer Gene Therapy by Country (2019-2024)
7.2 Europe Cancer Gene Therapy Market Size by Type (2019-2024)
7.3 Europe Cancer Gene Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cancer Gene Therapy by Region (2019-2024)
8.2 Middle East & Africa Cancer Gene Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Cancer Gene Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CANCER GENE THERAPY MARKET FORECAST
10.1 Global Cancer Gene Therapy Forecast by Regions (2025-2030)
10.1.1 Global Cancer Gene Therapy Forecast by Regions (2025-2030)
10.1.2 Americas Cancer Gene Therapy Forecast
10.1.3 APAC Cancer Gene Therapy Forecast
10.1.4 Europe Cancer Gene Therapy Forecast
10.1.5 Middle East & Africa Cancer Gene Therapy Forecast
10.2 Americas Cancer Gene Therapy Forecast by Country (2025-2030)
10.2.1 United States Cancer Gene Therapy Market Forecast
10.2.2 Canada Cancer Gene Therapy Market Forecast
10.2.3 Mexico Cancer Gene Therapy Market Forecast
10.2.4 Brazil Cancer Gene Therapy Market Forecast
10.3 APAC Cancer Gene Therapy Forecast by Region (2025-2030)
10.3.1 China Cancer Gene Therapy Market Forecast
10.3.2 Japan Cancer Gene Therapy Market Forecast
10.3.3 Korea Cancer Gene Therapy Market Forecast
10.3.4 Southeast Asia Cancer Gene Therapy Market Forecast
10.3.5 India Cancer Gene Therapy Market Forecast
10.3.6 Australia Cancer Gene Therapy Market Forecast
10.4 Europe Cancer Gene Therapy Forecast by Country (2025-2030)
10.4.1 Germany Cancer Gene Therapy Market Forecast
10.4.2 France Cancer Gene Therapy Market Forecast
10.4.3 UK Cancer Gene Therapy Market Forecast
10.4.4 Italy Cancer Gene Therapy Market Forecast
10.4.5 Russia Cancer Gene Therapy Market Forecast
10.5 Middle East & Africa Cancer Gene Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Cancer Gene Therapy Market Forecast
10.5.2 South Africa Cancer Gene Therapy Market Forecast
10.5.3 Israel Cancer Gene Therapy Market Forecast
10.5.4 Turkey Cancer Gene Therapy Market Forecast
10.5.5 GCC Countries Cancer Gene Therapy Market Forecast
10.6 Global Cancer Gene Therapy Forecast by Type (2025-2030)
10.7 Global Cancer Gene Therapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Adaptimmune
11.1.1 Adaptimmune Company Information
11.1.2 Adaptimmune Cancer Gene Therapy Product Offered
11.1.3 Adaptimmune Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Adaptimmune Main Business Overview
11.1.5 Adaptimmune Latest Developments
11.2 Bluebird bio
11.2.1 Bluebird bio Company Information
11.2.2 Bluebird bio Cancer Gene Therapy Product Offered
11.2.3 Bluebird bio Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bluebird bio Main Business Overview
11.2.5 Bluebird bio Latest Developments
11.3 Celgene
11.3.1 Celgene Company Information
11.3.2 Celgene Cancer Gene Therapy Product Offered
11.3.3 Celgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Celgene Main Business Overview
11.3.5 Celgene Latest Developments
11.4 Shanghai Sunway Biotech
11.4.1 Shanghai Sunway Biotech Company Information
11.4.2 Shanghai Sunway Biotech Cancer Gene Therapy Product Offered
11.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Shanghai Sunway Biotech Main Business Overview
11.4.5 Shanghai Sunway Biotech Latest Developments
11.5 Shenzhen SiBiono GeneTech
11.5.1 Shenzhen SiBiono GeneTech Company Information
11.5.2 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Offered
11.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Shenzhen SiBiono GeneTech Main Business Overview
11.5.5 Shenzhen SiBiono GeneTech Latest Developments
11.6 SynerGene Therapeutics
11.6.1 SynerGene Therapeutics Company Information
11.6.2 SynerGene Therapeutics Cancer Gene Therapy Product Offered
11.6.3 SynerGene Therapeutics Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 SynerGene Therapeutics Main Business Overview
11.6.5 SynerGene Therapeutics Latest Developments
11.7 Altor BioScience
11.7.1 Altor BioScience Company Information
11.7.2 Altor BioScience Cancer Gene Therapy Product Offered
11.7.3 Altor BioScience Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Altor BioScience Main Business Overview
11.7.5 Altor BioScience Latest Developments
11.8 Amgen
11.8.1 Amgen Company Information
11.8.2 Amgen Cancer Gene Therapy Product Offered
11.8.3 Amgen Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Amgen Main Business Overview
11.8.5 Amgen Latest Developments
11.9 Argenx
11.9.1 Argenx Company Information
11.9.2 Argenx Cancer Gene Therapy Product Offered
11.9.3 Argenx Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Argenx Main Business Overview
11.9.5 Argenx Latest Developments
11.10 BioCancell
11.10.1 BioCancell Company Information
11.10.2 BioCancell Cancer Gene Therapy Product Offered
11.10.3 BioCancell Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 BioCancell Main Business Overview
11.10.5 BioCancell Latest Developments
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Information
11.11.2 GlaxoSmithKline Cancer Gene Therapy Product Offered
11.11.3 GlaxoSmithKline Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 GlaxoSmithKline Main Business Overview
11.11.5 GlaxoSmithKline Latest Developments
11.12 Merck
11.12.1 Merck Company Information
11.12.2 Merck Cancer Gene Therapy Product Offered
11.12.3 Merck Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Merck Main Business Overview
11.12.5 Merck Latest Developments
11.13 OncoGenex Pharmaceuticals
11.13.1 OncoGenex Pharmaceuticals Company Information
11.13.2 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Offered
11.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 OncoGenex Pharmaceuticals Main Business Overview
11.13.5 OncoGenex Pharmaceuticals Latest Developments
11.14 Transgene
11.14.1 Transgene Company Information
11.14.2 Transgene Cancer Gene Therapy Product Offered
11.14.3 Transgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Transgene Main Business Overview
11.14.5 Transgene Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cancer Gene Therapy Market Size 2019-2030
2.1.2 Cancer Gene Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cancer Gene Therapy Segment by Type
2.2.1 Oncolytic Virotherapy
2.2.2 Gene Transfer
2.2.3 Gene-Induced Immunotherapy
2.3 Cancer Gene Therapy Market Size by Type
2.3.1 Cancer Gene Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
2.4 Cancer Gene Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics Centers
2.4.3 Research Institutes
2.5 Cancer Gene Therapy Market Size by Application
2.5.1 Cancer Gene Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cancer Gene Therapy Market Size Market Share by Application (2019-2024)
3 CANCER GENE THERAPY MARKET SIZE BY PLAYER
3.1 Cancer Gene Therapy Market Size Market Share by Players
3.1.1 Global Cancer Gene Therapy Revenue by Players (2019-2024)
3.1.2 Global Cancer Gene Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CANCER GENE THERAPY BY REGIONS
4.1 Cancer Gene Therapy Market Size by Regions (2019-2024)
4.2 Americas Cancer Gene Therapy Market Size Growth (2019-2024)
4.3 APAC Cancer Gene Therapy Market Size Growth (2019-2024)
4.4 Europe Cancer Gene Therapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Cancer Gene Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Cancer Gene Therapy Market Size by Country (2019-2024)
5.2 Americas Cancer Gene Therapy Market Size by Type (2019-2024)
5.3 Americas Cancer Gene Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Gene Therapy Market Size by Region (2019-2024)
6.2 APAC Cancer Gene Therapy Market Size by Type (2019-2024)
6.3 APAC Cancer Gene Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cancer Gene Therapy by Country (2019-2024)
7.2 Europe Cancer Gene Therapy Market Size by Type (2019-2024)
7.3 Europe Cancer Gene Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cancer Gene Therapy by Region (2019-2024)
8.2 Middle East & Africa Cancer Gene Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Cancer Gene Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CANCER GENE THERAPY MARKET FORECAST
10.1 Global Cancer Gene Therapy Forecast by Regions (2025-2030)
10.1.1 Global Cancer Gene Therapy Forecast by Regions (2025-2030)
10.1.2 Americas Cancer Gene Therapy Forecast
10.1.3 APAC Cancer Gene Therapy Forecast
10.1.4 Europe Cancer Gene Therapy Forecast
10.1.5 Middle East & Africa Cancer Gene Therapy Forecast
10.2 Americas Cancer Gene Therapy Forecast by Country (2025-2030)
10.2.1 United States Cancer Gene Therapy Market Forecast
10.2.2 Canada Cancer Gene Therapy Market Forecast
10.2.3 Mexico Cancer Gene Therapy Market Forecast
10.2.4 Brazil Cancer Gene Therapy Market Forecast
10.3 APAC Cancer Gene Therapy Forecast by Region (2025-2030)
10.3.1 China Cancer Gene Therapy Market Forecast
10.3.2 Japan Cancer Gene Therapy Market Forecast
10.3.3 Korea Cancer Gene Therapy Market Forecast
10.3.4 Southeast Asia Cancer Gene Therapy Market Forecast
10.3.5 India Cancer Gene Therapy Market Forecast
10.3.6 Australia Cancer Gene Therapy Market Forecast
10.4 Europe Cancer Gene Therapy Forecast by Country (2025-2030)
10.4.1 Germany Cancer Gene Therapy Market Forecast
10.4.2 France Cancer Gene Therapy Market Forecast
10.4.3 UK Cancer Gene Therapy Market Forecast
10.4.4 Italy Cancer Gene Therapy Market Forecast
10.4.5 Russia Cancer Gene Therapy Market Forecast
10.5 Middle East & Africa Cancer Gene Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Cancer Gene Therapy Market Forecast
10.5.2 South Africa Cancer Gene Therapy Market Forecast
10.5.3 Israel Cancer Gene Therapy Market Forecast
10.5.4 Turkey Cancer Gene Therapy Market Forecast
10.5.5 GCC Countries Cancer Gene Therapy Market Forecast
10.6 Global Cancer Gene Therapy Forecast by Type (2025-2030)
10.7 Global Cancer Gene Therapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Adaptimmune
11.1.1 Adaptimmune Company Information
11.1.2 Adaptimmune Cancer Gene Therapy Product Offered
11.1.3 Adaptimmune Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Adaptimmune Main Business Overview
11.1.5 Adaptimmune Latest Developments
11.2 Bluebird bio
11.2.1 Bluebird bio Company Information
11.2.2 Bluebird bio Cancer Gene Therapy Product Offered
11.2.3 Bluebird bio Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bluebird bio Main Business Overview
11.2.5 Bluebird bio Latest Developments
11.3 Celgene
11.3.1 Celgene Company Information
11.3.2 Celgene Cancer Gene Therapy Product Offered
11.3.3 Celgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Celgene Main Business Overview
11.3.5 Celgene Latest Developments
11.4 Shanghai Sunway Biotech
11.4.1 Shanghai Sunway Biotech Company Information
11.4.2 Shanghai Sunway Biotech Cancer Gene Therapy Product Offered
11.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Shanghai Sunway Biotech Main Business Overview
11.4.5 Shanghai Sunway Biotech Latest Developments
11.5 Shenzhen SiBiono GeneTech
11.5.1 Shenzhen SiBiono GeneTech Company Information
11.5.2 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Offered
11.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Shenzhen SiBiono GeneTech Main Business Overview
11.5.5 Shenzhen SiBiono GeneTech Latest Developments
11.6 SynerGene Therapeutics
11.6.1 SynerGene Therapeutics Company Information
11.6.2 SynerGene Therapeutics Cancer Gene Therapy Product Offered
11.6.3 SynerGene Therapeutics Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 SynerGene Therapeutics Main Business Overview
11.6.5 SynerGene Therapeutics Latest Developments
11.7 Altor BioScience
11.7.1 Altor BioScience Company Information
11.7.2 Altor BioScience Cancer Gene Therapy Product Offered
11.7.3 Altor BioScience Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Altor BioScience Main Business Overview
11.7.5 Altor BioScience Latest Developments
11.8 Amgen
11.8.1 Amgen Company Information
11.8.2 Amgen Cancer Gene Therapy Product Offered
11.8.3 Amgen Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Amgen Main Business Overview
11.8.5 Amgen Latest Developments
11.9 Argenx
11.9.1 Argenx Company Information
11.9.2 Argenx Cancer Gene Therapy Product Offered
11.9.3 Argenx Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Argenx Main Business Overview
11.9.5 Argenx Latest Developments
11.10 BioCancell
11.10.1 BioCancell Company Information
11.10.2 BioCancell Cancer Gene Therapy Product Offered
11.10.3 BioCancell Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 BioCancell Main Business Overview
11.10.5 BioCancell Latest Developments
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Information
11.11.2 GlaxoSmithKline Cancer Gene Therapy Product Offered
11.11.3 GlaxoSmithKline Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 GlaxoSmithKline Main Business Overview
11.11.5 GlaxoSmithKline Latest Developments
11.12 Merck
11.12.1 Merck Company Information
11.12.2 Merck Cancer Gene Therapy Product Offered
11.12.3 Merck Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Merck Main Business Overview
11.12.5 Merck Latest Developments
11.13 OncoGenex Pharmaceuticals
11.13.1 OncoGenex Pharmaceuticals Company Information
11.13.2 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Offered
11.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 OncoGenex Pharmaceuticals Main Business Overview
11.13.5 OncoGenex Pharmaceuticals Latest Developments
11.14 Transgene
11.14.1 Transgene Company Information
11.14.2 Transgene Cancer Gene Therapy Product Offered
11.14.3 Transgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Transgene Main Business Overview
11.14.5 Transgene Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cancer Gene Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Oncolytic Virotherapy
Table 3. Major Players of Gene Transfer
Table 4. Major Players of Gene-Induced Immunotherapy
Table 5. Cancer Gene Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Cancer Gene Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
Table 8. Cancer Gene Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Cancer Gene Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Cancer Gene Therapy Market Size Market Share by Application (2019-2024)
Table 11. Global Cancer Gene Therapy Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Cancer Gene Therapy Revenue Market Share by Player (2019-2024)
Table 13. Cancer Gene Therapy Key Players Head office and Products Offered
Table 14. Cancer Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cancer Gene Therapy Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Cancer Gene Therapy Market Size Market Share by Regions (2019-2024)
Table 19. Global Cancer Gene Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Cancer Gene Therapy Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Cancer Gene Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Cancer Gene Therapy Market Size Market Share by Country (2019-2024)
Table 23. Americas Cancer Gene Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
Table 25. Americas Cancer Gene Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Cancer Gene Therapy Market Size Market Share by Application (2019-2024)
Table 27. APAC Cancer Gene Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Cancer Gene Therapy Market Size Market Share by Region (2019-2024)
Table 29. APAC Cancer Gene Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
Table 31. APAC Cancer Gene Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Cancer Gene Therapy Market Size Market Share by Application (2019-2024)
Table 33. Europe Cancer Gene Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Cancer Gene Therapy Market Size Market Share by Country (2019-2024)
Table 35. Europe Cancer Gene Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
Table 37. Europe Cancer Gene Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Cancer Gene Therapy Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Cancer Gene Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Cancer Gene Therapy Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Cancer Gene Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Cancer Gene Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Cancer Gene Therapy Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Cancer Gene Therapy
Table 46. Key Market Challenges & Risks of Cancer Gene Therapy
Table 47. Key Industry Trends of Cancer Gene Therapy
Table 48. Global Cancer Gene Therapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Cancer Gene Therapy Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Cancer Gene Therapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Cancer Gene Therapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Adaptimmune Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 53. Adaptimmune Cancer Gene Therapy Product Offered
Table 54. Adaptimmune Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Adaptimmune Main Business
Table 56. Adaptimmune Latest Developments
Table 57. Bluebird bio Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 58. Bluebird bio Cancer Gene Therapy Product Offered
Table 59. Bluebird bio Main Business
Table 60. Bluebird bio Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Bluebird bio Latest Developments
Table 62. Celgene Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 63. Celgene Cancer Gene Therapy Product Offered
Table 64. Celgene Main Business
Table 65. Celgene Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Celgene Latest Developments
Table 67. Shanghai Sunway Biotech Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 68. Shanghai Sunway Biotech Cancer Gene Therapy Product Offered
Table 69. Shanghai Sunway Biotech Main Business
Table 70. Shanghai Sunway Biotech Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Shanghai Sunway Biotech Latest Developments
Table 72. Shenzhen SiBiono GeneTech Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 73. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Offered
Table 74. Shenzhen SiBiono GeneTech Main Business
Table 75. Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Shenzhen SiBiono GeneTech Latest Developments
Table 77. SynerGene Therapeutics Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 78. SynerGene Therapeutics Cancer Gene Therapy Product Offered
Table 79. SynerGene Therapeutics Main Business
Table 80. SynerGene Therapeutics Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. SynerGene Therapeutics Latest Developments
Table 82. Altor BioScience Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 83. Altor BioScience Cancer Gene Therapy Product Offered
Table 84. Altor BioScience Main Business
Table 85. Altor BioScience Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Altor BioScience Latest Developments
Table 87. Amgen Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 88. Amgen Cancer Gene Therapy Product Offered
Table 89. Amgen Main Business
Table 90. Amgen Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Amgen Latest Developments
Table 92. Argenx Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 93. Argenx Cancer Gene Therapy Product Offered
Table 94. Argenx Main Business
Table 95. Argenx Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Argenx Latest Developments
Table 97. BioCancell Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 98. BioCancell Cancer Gene Therapy Product Offered
Table 99. BioCancell Main Business
Table 100. BioCancell Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. BioCancell Latest Developments
Table 102. GlaxoSmithKline Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 103. GlaxoSmithKline Cancer Gene Therapy Product Offered
Table 104. GlaxoSmithKline Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. GlaxoSmithKline Main Business
Table 106. GlaxoSmithKline Latest Developments
Table 107. Merck Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 108. Merck Cancer Gene Therapy Product Offered
Table 109. Merck Main Business
Table 110. Merck Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Merck Latest Developments
Table 112. OncoGenex Pharmaceuticals Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 113. OncoGenex Pharmaceuticals Cancer Gene Therapy Product Offered
Table 114. OncoGenex Pharmaceuticals Main Business
Table 115. OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. OncoGenex Pharmaceuticals Latest Developments
Table 117. Transgene Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 118. Transgene Cancer Gene Therapy Product Offered
Table 119. Transgene Main Business
Table 120. Transgene Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Transgene Latest Developments
Table 1. Cancer Gene Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Oncolytic Virotherapy
Table 3. Major Players of Gene Transfer
Table 4. Major Players of Gene-Induced Immunotherapy
Table 5. Cancer Gene Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Cancer Gene Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
Table 8. Cancer Gene Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Cancer Gene Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Cancer Gene Therapy Market Size Market Share by Application (2019-2024)
Table 11. Global Cancer Gene Therapy Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Cancer Gene Therapy Revenue Market Share by Player (2019-2024)
Table 13. Cancer Gene Therapy Key Players Head office and Products Offered
Table 14. Cancer Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cancer Gene Therapy Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Cancer Gene Therapy Market Size Market Share by Regions (2019-2024)
Table 19. Global Cancer Gene Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Cancer Gene Therapy Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Cancer Gene Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Cancer Gene Therapy Market Size Market Share by Country (2019-2024)
Table 23. Americas Cancer Gene Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
Table 25. Americas Cancer Gene Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Cancer Gene Therapy Market Size Market Share by Application (2019-2024)
Table 27. APAC Cancer Gene Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Cancer Gene Therapy Market Size Market Share by Region (2019-2024)
Table 29. APAC Cancer Gene Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
Table 31. APAC Cancer Gene Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Cancer Gene Therapy Market Size Market Share by Application (2019-2024)
Table 33. Europe Cancer Gene Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Cancer Gene Therapy Market Size Market Share by Country (2019-2024)
Table 35. Europe Cancer Gene Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
Table 37. Europe Cancer Gene Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Cancer Gene Therapy Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Cancer Gene Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Cancer Gene Therapy Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Cancer Gene Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Cancer Gene Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Cancer Gene Therapy Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Cancer Gene Therapy
Table 46. Key Market Challenges & Risks of Cancer Gene Therapy
Table 47. Key Industry Trends of Cancer Gene Therapy
Table 48. Global Cancer Gene Therapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Cancer Gene Therapy Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Cancer Gene Therapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Cancer Gene Therapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Adaptimmune Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 53. Adaptimmune Cancer Gene Therapy Product Offered
Table 54. Adaptimmune Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Adaptimmune Main Business
Table 56. Adaptimmune Latest Developments
Table 57. Bluebird bio Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 58. Bluebird bio Cancer Gene Therapy Product Offered
Table 59. Bluebird bio Main Business
Table 60. Bluebird bio Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Bluebird bio Latest Developments
Table 62. Celgene Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 63. Celgene Cancer Gene Therapy Product Offered
Table 64. Celgene Main Business
Table 65. Celgene Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Celgene Latest Developments
Table 67. Shanghai Sunway Biotech Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 68. Shanghai Sunway Biotech Cancer Gene Therapy Product Offered
Table 69. Shanghai Sunway Biotech Main Business
Table 70. Shanghai Sunway Biotech Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Shanghai Sunway Biotech Latest Developments
Table 72. Shenzhen SiBiono GeneTech Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 73. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Offered
Table 74. Shenzhen SiBiono GeneTech Main Business
Table 75. Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Shenzhen SiBiono GeneTech Latest Developments
Table 77. SynerGene Therapeutics Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 78. SynerGene Therapeutics Cancer Gene Therapy Product Offered
Table 79. SynerGene Therapeutics Main Business
Table 80. SynerGene Therapeutics Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. SynerGene Therapeutics Latest Developments
Table 82. Altor BioScience Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 83. Altor BioScience Cancer Gene Therapy Product Offered
Table 84. Altor BioScience Main Business
Table 85. Altor BioScience Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Altor BioScience Latest Developments
Table 87. Amgen Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 88. Amgen Cancer Gene Therapy Product Offered
Table 89. Amgen Main Business
Table 90. Amgen Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Amgen Latest Developments
Table 92. Argenx Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 93. Argenx Cancer Gene Therapy Product Offered
Table 94. Argenx Main Business
Table 95. Argenx Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Argenx Latest Developments
Table 97. BioCancell Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 98. BioCancell Cancer Gene Therapy Product Offered
Table 99. BioCancell Main Business
Table 100. BioCancell Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. BioCancell Latest Developments
Table 102. GlaxoSmithKline Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 103. GlaxoSmithKline Cancer Gene Therapy Product Offered
Table 104. GlaxoSmithKline Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. GlaxoSmithKline Main Business
Table 106. GlaxoSmithKline Latest Developments
Table 107. Merck Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 108. Merck Cancer Gene Therapy Product Offered
Table 109. Merck Main Business
Table 110. Merck Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Merck Latest Developments
Table 112. OncoGenex Pharmaceuticals Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 113. OncoGenex Pharmaceuticals Cancer Gene Therapy Product Offered
Table 114. OncoGenex Pharmaceuticals Main Business
Table 115. OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. OncoGenex Pharmaceuticals Latest Developments
Table 117. Transgene Details, Company Type, Cancer Gene Therapy Area Served and Its Competitors
Table 118. Transgene Cancer Gene Therapy Product Offered
Table 119. Transgene Main Business
Table 120. Transgene Cancer Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Transgene Latest Developments
LIST OF FIGURES
Figure 1. Cancer Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Gene Therapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Cancer Gene Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cancer Gene Therapy Sales Market Share by Country/Region (2023)
Figure 8. Cancer Gene Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cancer Gene Therapy Market Size Market Share by Type in 2023
Figure 10. Cancer Gene Therapy in Hospitals
Figure 11. Global Cancer Gene Therapy Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Cancer Gene Therapy in Diagnostics Centers
Figure 13. Global Cancer Gene Therapy Market: Diagnostics Centers (2019-2024) & ($ Millions)
Figure 14. Cancer Gene Therapy in Research Institutes
Figure 15. Global Cancer Gene Therapy Market: Research Institutes (2019-2024) & ($ Millions)
Figure 16. Global Cancer Gene Therapy Market Size Market Share by Application in 2023
Figure 17. Global Cancer Gene Therapy Revenue Market Share by Player in 2023
Figure 18. Global Cancer Gene Therapy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Cancer Gene Therapy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Cancer Gene Therapy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Cancer Gene Therapy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Cancer Gene Therapy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Cancer Gene Therapy Value Market Share by Country in 2023
Figure 24. United States Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Cancer Gene Therapy Market Size Market Share by Region in 2023
Figure 29. APAC Cancer Gene Therapy Market Size Market Share by Type in 2023
Figure 30. APAC Cancer Gene Therapy Market Size Market Share by Application in 2023
Figure 31. China Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Cancer Gene Therapy Market Size Market Share by Country in 2023
Figure 38. Europe Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Cancer Gene Therapy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Cancer Gene Therapy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Cancer Gene Therapy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 57. United States Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 61. China Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 65. India Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 68. France Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 69. UK Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 78. Global Cancer Gene Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Cancer Gene Therapy Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Cancer Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Gene Therapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Cancer Gene Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cancer Gene Therapy Sales Market Share by Country/Region (2023)
Figure 8. Cancer Gene Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cancer Gene Therapy Market Size Market Share by Type in 2023
Figure 10. Cancer Gene Therapy in Hospitals
Figure 11. Global Cancer Gene Therapy Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Cancer Gene Therapy in Diagnostics Centers
Figure 13. Global Cancer Gene Therapy Market: Diagnostics Centers (2019-2024) & ($ Millions)
Figure 14. Cancer Gene Therapy in Research Institutes
Figure 15. Global Cancer Gene Therapy Market: Research Institutes (2019-2024) & ($ Millions)
Figure 16. Global Cancer Gene Therapy Market Size Market Share by Application in 2023
Figure 17. Global Cancer Gene Therapy Revenue Market Share by Player in 2023
Figure 18. Global Cancer Gene Therapy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Cancer Gene Therapy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Cancer Gene Therapy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Cancer Gene Therapy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Cancer Gene Therapy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Cancer Gene Therapy Value Market Share by Country in 2023
Figure 24. United States Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Cancer Gene Therapy Market Size Market Share by Region in 2023
Figure 29. APAC Cancer Gene Therapy Market Size Market Share by Type in 2023
Figure 30. APAC Cancer Gene Therapy Market Size Market Share by Application in 2023
Figure 31. China Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Cancer Gene Therapy Market Size Market Share by Country in 2023
Figure 38. Europe Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Cancer Gene Therapy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Cancer Gene Therapy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Cancer Gene Therapy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Cancer Gene Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 57. United States Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 61. China Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 65. India Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 68. France Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 69. UK Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Cancer Gene Therapy Market Size 2025-2030 ($ Millions)
Figure 78. Global Cancer Gene Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Cancer Gene Therapy Market Size Market Share Forecast by Application (2025-2030)
